Neopterin negatively regulates expression of ABCA1 and ABCG1 by the LXRα signaling pathway in THP-1 macrophage-derived foam cells

Molecular and Cellular Biochemistry

Volumn 379, Issue 1-2, 2013, Pages 123-131

  Yan, Jin Quan ^a   Tan, Chun Zhi ^b,c   Wu, Jin Hua ^d   Zhang, Dong Cui ^e   Chen, Ji Ling ^f   Zeng, Bin Yuan ^b   Jiang, Yu Ping ^b   Nie, Jin ^b   Liu, Wei ^b   Liu, Qin ^b   Dai, Hao ^b  

^a Shaoyang Medical College   (China)

^b First People's Hospital of ShaoYang City   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d THE SECOND AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^e Department of Radiation Oncology   (China)

^f No 3 Hospital of Wuhan City   (China)

Author keywords

ABCA1; Atherosclerosis; Cholesterol efflux; LXR ; Neopterin

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; LIVER X RECEPTOR ALPHA; MESSENGER RNA; NEOPTERIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SMALL INTERFERING RNA;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL EFFLUX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EFFUSION; FOAM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID SCINTILLATION COUNTING; MACROPHAGE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CHOLESTEROL; DOWN-REGULATION; FOAM CELLS; GENE EXPRESSION REGULATION; HUMANS; HYDROCARBONS, FLUORINATED; NEOPTERIN; ORPHAN NUCLEAR RECEPTORS; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84878433706     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1634-6     Document Type: Article

References (43)

1. Yin K, Liao DF, Tang CK (2010) ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol Med 16:438-449
2. Frisdal E, Lesnik P, Olivier M et al (2011) Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem 286:30926-30936
3. De Rosa S, Cirillo P, Pacileo M et al (2011) Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. Curr Vasc Pharmacol 9:188-199
4. Sugioka K, Naruko T, Matsumura Y et al (2010) Neopterin and atherosclerotic plaque instability in coronary and carotid arteries. J Atheroscler Thromb 17:1115-1121
5. Gieseg SP, Crone EM, Flavall EA, Amit Z (2008) Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br J Pharmacol 153:627-635
6. Avanzas P, Arroyo-Espliguero R, Quiles J et al (2005) Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 26:457-463
7. Grammer TB, Fuchs D, Boehm BO et al (2009) Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 55:1135-1146
8. Sugioka K, Naruko T, Hozumi T et al (2010) Elevated levels of neopterin are associated with carotid plaques with complex morphology in patients with stable angina pectoris. Atherosclerosis 208:524-530
9. Adachi T, Naruko T, Itoh A et al (2007) Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions. Heart 93:1537-1541
10. Fuchs D, Avanzas P, Arroyo-Espliguero R et al (2009) The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem 16:4644-4653
11. Oxenkrug G, Tucker KL, Requintina P, Summergrad P (2011) Neopterin, a marker of interferon-gamma-inducible inflammation, correlates with pyridoxal-5′-phosphate, waist circumference, HDL-cholesterol, insulin resistance and mortality risk in adult Boston community dwellers of Puerto Rican origin. Am J Neuroprot Neuroregen 3:48-52
12. Ku CS, Park Y, Coleman SL, Lee J (2012) Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages. J Nutr Biochem 23:1271-1276
13. Ozasa H, Ayaori M, Iizuka M et al (2011) Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPAR gamma/LXR alpha pathway: findings from in vitro and ex vivo studies. Atherosclerosis 219:141-150
14. Xu Y, Bao Y, Hong B, Si S (2011) Identification of dehydroxytrichostatin A as a novel up-regulator of the ATP-binding cassette transporter A1 (ABCA1). Molecules 16:7183-7198
15. Liu Y, Tang C (2012) Regulation of ABCA1 functions by signaling pathways. Biochim Biophys Acta 1821:522-529
16. Wang J, Burnett JR, Near S et al (2000) Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 20:1983-1989
17. Hong SH, Rhyne J, Zeller K, Miller M (2002) ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. Atherosclerosis 164:245-250
18. Schmitz G, Langmann T (2005) Transcriptional regulatory networks in lipid metabolism control ABCA1 expression. Biochim Biophys Acta 1735:1-19
19. Li T, Chen W, Chiang JY (2007) PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 48:373-384
20. Zanotti I, Poti F, Pedrelli M et al (2008) The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential. J Lipid Res 49:954-960
21. Kuipers I, Li J, Vreeswijk-Baudoin I et al (2010) Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo. Eur J Heart Fail 12:1042-1050
22. Honzumi S, Shima A, Hiroshima A et al (2011) Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand white rabbits. Biochim Biophys Acta 1811:1136-1145
23. Bahrehmand F, Vaisi-Raygani A, Kiani A et al (2012) Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Lupus 21:616-624
24. Forsblad J, Gottsater A, Persson K et al (2002) Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology. Int Angiol 21:173-179
25. Chen SG, Xiao J, Liu XH et al (2010) Ibrolipim increases ABCA1/G1 expression by the LXR alpha signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacol Sin 31:1343-1349
26. Hu YW, Ma X, Li XX et al (2009) Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 204:e35-e43
27. Rho YH, Solus J, Raggi P et al (2011) Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 63:535-541
28. Ray KK, Morrow DA, Sabatine MS et al (2007) Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 115:3071-3078
29. Fuchs D, Jamnig H, Heininger P et al (2012) Decline of exhaled isoprene in lung cancer patients correlates with immune activation. J Breath Res 6:027101
30. Herpfer I, Greilberger J, Ledinski G et al (2002) Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Free Radic Res 36:509-520
31. Ilhan F, Akbulut H, Karaca I et al (2005) Procalcitonin, c-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiol 60:361-365
32. Ueland T, Vissers MN, Wiegman A et al (2006) Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 36:147-152
33. Ku CS, Rasmussen HE, Park Y et al (2011) Unsaturated fatty acids repress the expression of ATP-binding cassette transporter A1 in HepG2 and FHs 74 Int cells. Nutr Res 31:278-285
34. Rubic T, Lorenz RL (2006) Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res 69:527-535
35. Imaizumi S, Miura S, Nakamura K et al (2008) Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol 51:1604-1612
36. Agassandian M, Miakotina OL, Andrews M et al (2007) Pseudomonas aeruginosa and sPLA2 IB stimulate ABCA1-mediated phospholipid efflux via ERK-activation of PPAR alpha-RXR. Biochem J 403:409-420
37. Shridas P, Bailey WM, Gizard F et al (2010) Group X secretory phospholipase A2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages. Arterioscler Thromb Vasc Biol 30:2014-2021
38. Hao XR, Cao DL, Hu YW et al (2009) IFN-gamma down-regulates ABCA1 expression by inhibiting LXR alpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 203:417-428
39. Huwait EA, Greenow KR, Singh NN, Ramji DP (2011) A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression. Cell Signal 23:542-549
40. Oberkofler H, Schraml E, Krempler F, Patsch W (2003) Potentiation of liver X receptor transcriptional activity by peroxisome-proliferator-activated receptor gamma co-activator 1 alpha. Biochem J 371:89-96
41. Tiano JP, Mauvais-Jarvis F (2012) Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic beta-cells. Endocrinology 153:2997-3005
42. Dong SZ, Zhao SP, Wu ZH et al (2011) Curcumin promotes cholesterol efflux from adipocytes related to PPAR gamma-LXR alpha-ABCA1 passway. Mol Cell Biochem 358:281-285
43. Hebanowska A (2011) Mechanisms of bile acid biosynthesis regulation-autoregulation by bile acids. Postepy Biochem 57:314-323